NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC (http://www.terrapinn.com/usaflu). These data clearly established that the new version of FluCide™ is superior to the older version.
More...
iHav.net - Your Uncensored Offtopic Community
If this is your first visit, please click the Sign Up now button to begin the process of creating your account so you can begin posting on our forums! The Sign Up process will only take up about a minute of two of your time.
|
|
|
Results 1 to 1 of 1
-
11-24-2009, 01:31 PM #1Senior Member
- Join Date
- Mar 2008
- Posts
- 12,518
- Downloads
- 0
- Uploads
- 0
NanoViricides Presents FluCide™ Animal Study Data At Influenza Congress - Now Improve
Reply With QuoteSimilar Threads
-
Do you think the U.S. will improve since Congress is on their 4 week vacation?
By waldoroja in forum Travel and VacationReplies: 1Last Post: 09-19-2011, 04:05 AM -
Bioject Announces Results Of Intradermal Dose Sparing Influenza Study Conducted By Th
By ! D33NA ! in forum Health and FitnessReplies: 0Last Post: 05-02-2010, 12:00 PM -
Amarillo Biosciences, Inc. -- Report On Australian Oral Interferon Influenza Study Is
By ! D33NA ! in forum Health and FitnessReplies: 0Last Post: 04-12-2010, 12:11 PM -
Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study
By ! D33NA ! in forum Health and FitnessReplies: 0Last Post: 03-06-2010, 01:00 PM -
NanoViricides Presents FluCide™ Animal Study Data At Influenza Congress - Now Improve
By ! D33NA ! in forum Health and FitnessReplies: 0Last Post: 11-24-2009, 01:32 PM
Bookmarks